Zevra Therapeutics, Inc. (ZVRA)
11.65
-0.22
(-1.85%)
USD |
NASDAQ |
Aug 24, 16:00
11.66
+0.01
(+0.09%)
After-Hours: 20:00
Zevra Therapeutics Debt to Equity Ratio : 0.0069 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0069 |
| March 31, 2026 | 0.0056 |
| December 31, 2025 | 0.4087 |
| September 30, 2025 | 0.471 |
| June 30, 2025 | 0.5312 |
| March 31, 2025 | 1.507 |
| December 31, 2024 | 1.520 |
| September 30, 2024 | 0.8589 |
| June 30, 2024 | 1.831 |
| March 31, 2024 | 0.9072 |
| December 31, 2023 | 0.7074 |
| September 30, 2023 | 0.6644 |
| June 30, 2023 | 0.2014 |
| March 31, 2023 | 0.1978 |
| December 31, 2022 | 0.1881 |
| September 30, 2022 | 0.1518 |
| June 30, 2022 | 0.1447 |
| March 31, 2022 | 0.0124 |
| December 31, 2021 | 0.0127 |
| September 30, 2021 | 0.013 |
| June 30, 2021 | 0.0139 |
| March 31, 2021 | 0.0326 |
| December 31, 2020 | -1.062 |
| September 30, 2020 | -1.106 |
| Date | Value |
|---|---|
| June 30, 2020 | -1.120 |
| March 31, 2020 | -1.035 |
| December 31, 2019 | -1.074 |
| September 30, 2019 | -1.134 |
| June 30, 2019 | -1.042 |
| March 31, 2019 | -1.126 |
| December 31, 2018 | -1.233 |
| September 30, 2018 | -0.9562 |
| June 30, 2018 | -1.087 |
| March 31, 2018 | -1.178 |
| December 31, 2017 | -1.625 |
| September 30, 2017 | -1.924 |
| June 30, 2017 | -2.346 |
| March 31, 2017 | -2.703 |
| December 31, 2016 | -4.885 |
| September 30, 2016 | -9.272 |
| June 30, 2016 | 277.77 |
| March 31, 2016 | -7.994 |
| December 31, 2015 | -2.282 |
| September 30, 2015 | -10.99 |
| June 30, 2015 | 5.816 |
| March 31, 2015 | -0.7116 |
| December 31, 2014 | -0.7032 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Innoviva, Inc. | 0.2187 |
| Collegium Pharmaceutical, Inc. | 3.905 |
| Johnson & Johnson | 0.5771 |
| Ligand Pharmaceuticals, Inc. | 1.169 |
| Harrow, Inc. | 19.79 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 302.71M |
| Total Liabilities (Quarterly) | 85.06M |
| Shareholders Equity (Quarterly) | 217.65M |
| Current Ratio | 5.167 |
| Net Debt Paydown Yield | 1.42% |